Onconic Therapeutics온코닉테라퓨틱스
476060 · KOSDAQ · ₩476060 · 온코닉테라퓨틱스
₩12,770▲ ₩420 (3.40%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | 21.1% | 23.6% | −32.3% |
| Net margin | 24.0% | 29.6% | −54.5% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | +53.9% | +259.8% | — |
| Operating income growth | +37.1% | +363.0% | — |
| Net income growth | +24.9% | +295.0% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 25.0% | 24.7% | −14.4% |
| Return on assets | 23.4% | 23.1% | −13.3% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 8.4% | 5.1% | 8.7% |
| Net debt to equity | — | −65.3% | −76.8% |
| Current ratio | 1,139.1% | 1,762.2% | 1,094.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Onconic Therapeutics / 온코닉테라퓨틱스 / 476060 / KRX:476060
Source: KRX statistical information